Rho GTPase regulation by miRNAs and covalent modifications

Trends in Cell Biology

Volumn 22, Issue 7, 2012, Pages 365-373

  Liu, Ming ^a   Bi, Feng ^b   Zhou, Xuan ^a   Zheng, Yi ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

MicroRNAs; Phosphorylation; Small GTPases; Transglutamination; Ubiquitination

Indexed keywords

GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATE; MICRORNA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

CELL FUNCTION; ENZYME ANALYSIS; ENZYME MODIFICATION; ENZYME REGULATION; HUMAN; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICRORNAS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RHO GTP-BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84862773457     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2012.04.004     Document Type: Review

References (103)

1. Etienne-Manneville S., et al. Rho GTPases in cell biology. Nature 2002, 420:629-635.
2. Jaffe A.B., Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005, 21:247-269.
3. Wang L., Zheng Y. Cell type-specific functions of Rho GTPases revealed by gene targeting in mice. Trends Cell Biol. 2007, 17:58-64.
4. Heasman S.J., Ridley A.J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 2008, 9:690-701.
5. Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2:133-142.
6. Newey S.E., et al. Rho GTPases, dendritic structure, and mental retardation. J. Neurobiol. 2005, 64:58-74.
7. Boettner B., Van Aelst L. The role of Rho GTPases in disease development. Gene 2002, 286:155-174.
8. Mulloy J.C., et al. Rho GTPases in hematopoiesis and hemopathies. Blood 2010, 115:936-947.
9. Zugaza J.L., et al. Inverted signaling hierarchy between RAS and RAC in T-lymphocytes. Oncogene 2004, 23:5823-5833.
10. Watabe-Uchida M., et al. Regulators of Rho GTPases in neuronal development. J. Neurosci. 2006, 26:10633-10655.
11. Bustelo X.R., et al. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 2007, 29:356-370.
12. Bishop A.L., Hall A. Rho GTPases and their effector proteins. Biochem. J. 2000, 348:241-255.
13. DerMardirossian C., et al. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 2005, 15:356-363.
14. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 2001, 26:724-732.
15. Moon S.Y., Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol. 2003, 13:13-22.
16. Schmidt A., Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Gene Dev. 2002, 16:1587-1609.
17. Rossman K.L., et al. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 2005, 6:167-180.
18. Boulter E., et al. Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1. Nat. Cell Biol. 2010, 12:477-483.
19. Griffiths-Jones S., et al. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
20. Chi S.W., et al. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
21. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
22. Lai E.C. MicroRNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 2002, 30:363-364.
23. Carè A., et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13:613-618.
24. Qian L., et al. Tinman/Nkx2-5 acts via miR-1 and upstream of Cdc42 to regulate heart function across species. J. Cell Biol. 2011, 193:1181-1196.
25. Yu J.Y., et al. MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp. Cell Res. 2008, 314:2618-2633.
26. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
27. Valastyan S., et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
28. Valastyan S., et al. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res. 2010, 70:5147-5154.
29. Kong W., et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 2008, 28:6773-6784.
30. Ma L., et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
31. Bandres E., et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 2009, 125:2723-2743.
32. Chen Q., et al. miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig. Dis. Sci. 2011, 56:2009-2016.
33. Liu M., et al. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int. J. Cancer 2011, 128:1269-1279.
34. Liu M., et al. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett. 2011, 301:151-160.
35. Park S.Y., et al. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol. 2009, 16:23-29.
36. Asangani I.A., et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
37. Chan J.A., et al. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
38. Liu M., et al. miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett. 2011, 585:2998-3005.
39. Connolly E.C., et al. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol. Cancer Res. 2010, 8:691-700.
40. Xia W., et al. MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol. Cell. Biochem. 2010, 344:261-266.
41. Roberts P.J., et al. Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J. Biol. Chem. 2008, 283:25150-25163.
42. Mitin N., et al. Posttranslational lipid modification of Rho family small GTPases. Methods Mol. Biol. 2012, 827:87-95.
43. Navarro-Lérida I., et al. A palmitoylation switch mechanism regulates Rac1 function and membrane organization. EMBO J. 2011, 31:534-551.
44. Pérez-Sala D., et al. The C-terminal sequence of RhoB directs protein degradation through an endo-lysosomal pathway. PLoS ONE 2009, 4:e8117.
45. Berzat A.C., et al. Transforming activity of the Rho family GTPase, Wrch-1, a Wnt-regulated Cdc42 homolog, is dependent on a novel carboxyl-terminal palmitoylation motif. J. Biol. Chem. 2005, 280:33055-33065.
46. Chenette E.J., et al. Critical and distinct roles of amino- and carboxyl-terminal sequences in regulation of the biological activity of the Chp atypical Rho GTPase. J. Biol. Chem. 2005, 280:13784-13792.
47. Castro-Castro A., et al. Coronin 1A promotes a cytoskeletal-based feedback loop that facilitates Rac1 translocation and activation. EMBO J. 2011, 30:3913-3927.
48. Williams C.L. The polybasic region of Ras and Rho family small GTPases: a regulator of protein interactions and membrane association and a site of nuclear localization signal sequences. Cell. Signal. 2003, 15:1071-1080.
49. Lanning C.C., et al. Novel mechanism of the co-regulation of nuclear transport of SmgGDS and Rac1. J. Biol. Chem. 2003, 278:12495-12506.
50. Lanning C.C., et al. The Rac1 C-terminal polybasic region regulates the nuclear localization and protein degradation of Rac1. J. Biol. Chem. 2004, 279:44197-44210.
51. Sandrock K., et al. The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin alpha2. Traffic 2010, 11:198-209.
52. Scholz R.P., et al. DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling. J. Cell Sci. 2009, 122:92-102.
53. Tanaka T., et al. Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. J. Biol. Chem. 2006, 281:15320-15329.
54. Yokoo T., et al. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J. Biol. Chem. 2003, 278:52919-52923.
55. Dubash A.D., et al. The small GTPase RhoA localizes to the nucleus and is activated by Net1 and DNA damage signals. PLoS ONE 2011, 6:e17380.
56. Visvikis O., et al. Direct modifications of Rho proteins: deconstructing GTPase regulation. Biol. Cell 2010, 102:377-389.
57. Castillo-Lluva S., et al. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat. Cell Biol. 2010, 12:1078-1085.
58. Flatau G., et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997, 387:729-733.
59. Schmidt G., et al. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 1997, 387:725-729.
60. Singh U.S., et al. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J. 2001, 20:2413-2423.
61. Singh U.S., et al. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Biol. Chem. 2003, 278:391-399.
62. Guilluy C., et al. Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J. Biol. Chem. 2007, 282:2918-2928.
63. Guilluy C., et al. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am. J. Respir. Crit. Care Med. 2009, 179:1151-1158.
64. Lang P., et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 1996, 15:510-519.
65. Sauzeau V., et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 2000, 275:21722-21729.
66. Tu S., et al. Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase. J. Biol. Chem. 2003, 278:49293-49300.
67. Kwon T., et al. Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1. J. Biol. Chem. 2000, 275:423-428.
68. Ellerbroek S.M., et al. Serine phosphorylation negatively regulates RhoA in vivo. J. Biol. Chem. 2003, 278:19023-19031.
69. Nusser N., et al. Serine phosphorylation differentially affects RhoA binding to effectors: implications to NGF-induced neurite outgrowth. Cell. Signal. 2006, 18:704-714.
70. Savoia C., et al. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J. Hypertens. 2005, 23:1037-1045.
71. Rolli-Derkinderen M., et al. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ. Res. 2005, 96:1152-1160.
72. Sauzeau V., et al. The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells. J. Clin. Invest. 2010, 120:315-330.
73. Riento K., et al. RhoE function is regulated by ROCK I-mediated phosphorylation. EMBO J. 2005, 24:1170-1180.
74. Tillement V., et al. Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization. Exp. Cell Res. 2008, 314:2811-2821.
75. Gu Y., et al. RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nat. Immunol. 2006, 7:1182-1190.
76. Loirand G., et al. Regulation of Rho proteins by phosphorylation in the cardiovascular system. Trends Cardiovasc. Med. 2006, 16:199-204.
77. Shao F., et al. A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 2002, 109:575-588.
78. Yarbrough M.L., et al. AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science 2009, 323:269-272.
79. Worby C.A., et al. The fic domain: regulation of cell signaling by adenylylation. Mol. Cell 2009, 34:93-103.
80. Kinch L.N., et al. Fido, a novel AMPylation domain common to fic, doc, and AvrB. PLoS ONE 2009, 4:e5818.
81. Aktories K. Bacterial protein toxins that modify host regulatory GTPases. Nat. Rev. Microbiol. 2011, 9:487-498.
82. Kerscher O., et al. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006, 22:159-180.
83. Doye A., et al. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 2002, 111:553-564.
84. Kovacic H.N., et al. Redox regulation of human Rac1 stability by the proteasome in human aortic endothelial cells. J. Biol. Chem. 2001, 276:45856-45861.
85. Lynch E.A., et al. Proteasome-mediated degradation of Rac1-GTP during epithelial cell scattering. Mol. Biol. Cell 2006, 17:2236-2242.
86. Nethe M., et al. Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway. J. Cell Sci. 2010, 123:1948-1958.
87. Nethe M., Hordijk P.L. The role of ubiquitylation and degradation in RhoGTPase signalling. J. Cell Sci. 2010, 123:4011-4018.
88. Visvikis O., et al. Activated Rac1, but not the tumorigenic variant Rac1b, is ubiquitinated on Lys 147 through a JNK-regulated process. FEBS J. 2008, 275:386-396.
89. Torrino S., et al. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1. Dev. Cell 2011, 21:959-965.
90. Zhang Y., et al. Smurf1: a link between cell polarity and ubiquitination. Cell Cycle 2004, 3:391-392.
91. Ozdamar B., et al. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005, 307:1603-1609.
92. Wang H.R., et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003, 302:1775-1779.
93. Wang H.R., et al. Degradation of RhoA by Smurf1 ubiquitin ligase. Methods Enzymol. 2006, 406:437-447.
94. Tian M., et al. Binding of RhoA by the C2 domain of E3 ligase Smurf1 is essential for Smurf1-regulated RhoA ubiquitination and cell protrusive activity. FEBS Lett. 2011, 585:2199-2204.
95. Bryan B., et al. Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth. FEBS Lett. 2005, 579:1015-1019.
96. Sahai E., et al. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J. Cell Biol. 2007, 176:35-42.
97. Chen Y., et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol. Cell 2009, 35:841-855.
98. de la Vega M., et al. The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. Nat. Commun. 2011, 2:259.
99. Yoon Y.S., et al. RhoB is epigenetically regulated in an age- and tissue-specific manner. Biochem. Biophys. Res. Commun. 2007, 362:164-169.
100. Chen J., et al. Epigenetic modification of RhoE expression in gastric cancer cells. Oncol. Rep. 2011, 25:173-180.
101. Tcherkezian J., et al. The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA. Biol. Cell 2006, 98:445-456.
102. Itoh R.E., et al. Phosphorylation and activation of the Rac1 and Cdc42 GEF Asef in A431 cells stimulated by EGF. J. Cell Sci. 2008, 121:2635-2642.
103. Guilluy C., et al. Rho protein crosstalk: another social network?. Trends Cell Biol. 2011, 21:718-726.